Myopia
Not recruitingStudy of Atropine Sulfate eye drops (0.
Study of Atropine Sulfate eye drops (0.
- Disease:Myopia
- Substances:Atropine Sulfate
Hungary- Participants:0–17 years
- Substances:Atropine Sulfate
- Sponsor:Ocumension (Hong Kong) Ltd.
Rare diseases
Investigational molecules
Locations
Back to Hungary556 clinical trials in Debrecen, Hungary across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of Atropine Sulfate eye drops (0.
HungaryStudy of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety
HungaryStudy on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer
HungaryStudy on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation
HungaryStudy on BI 706321 and Ustekinumab for Patients with Moderate to Severe Crohn's Disease
HungaryStudy on the Safety and Effectiveness of Motixafortide and G-CSF for Stem Cell Collection in Patients with Multiple Myeloma
HungaryStudy on the Effects of Ianalumab with Standard Therapy for Patients with Active Lupus Nephritis
HungaryStudy on the Effectiveness and Safety of Iptacopan for Patients with Primary IgA Nephropathy
HungaryStudy on the Effectiveness of Ruxolitinib Cream for Adults with Moderate Atopic Dermatitis
HungaryStudy on the Effects and Safety of Guselkumab for Patients with Active Psoriatic Arthritis
HungaryStudy Comparing Abelacimab and Apixaban for Preventing Blood Clots in Cancer Patients
HungaryStudy on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer
HungaryThe busiest research cities in the country
What the registry says about research in the country
Comprehensive studies evaluating novel treatments for plaque psoriasis and chronic urticaria. Multiple trials are investigating innovative therapies for both moderate to severe cases, including genital manifestations.
Focus on long-term safety and efficacy of new therapeutic agents for chronic skin conditions.
Leading research into heart failure prevention and cardiovascular disease management. Trials examining innovative treatments and preventive approaches for high-risk patients.
Emphasis on reducing major cardiovascular events and improving patient outcomes.
Groundbreaking research addressing obesity and type 2 diabetes. Studies evaluating combination therapies and novel approaches for weight management in diverse patient populations.
Investigation of treatments combining weight reduction with diabetes management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.